PCN388 - PATIENT REPORTED OUTCOMES IN THE CASTRATION RESISTANT PROSTATE CANCER REGISTRY (PRO-CAPRI) IN THE NETHERLANDS

Castration Resistant ◽

Management of Enzalutamide Related Adverse Events for Castration Resistant Prostate Cancer by Patient Reported Outcomes

Annals of Oncology ◽

10.1093/annonc/mdw521.017 ◽

2016 ◽

Vol 27 ◽

pp. vii78-vii79

Author(s):

Taro Iguchi ◽

Sayaka Yasuda ◽

Minoru Kato ◽

Takeshi Yamazaki ◽

Satoshi Tamada ◽

...

Keyword(s):

Prostate Cancer ◽

Adverse Events ◽

Castration Resistant ◽

Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(18)30898-2 ◽

2019 ◽

Vol 20 (4) ◽

pp. 556-569 ◽

Cited By ~ 30

Author(s):

Bertrand Tombal ◽

Fred Saad ◽

David Penson ◽

Maha Hussain ◽

Cora N Sternberg ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 3 ◽

Double Blind ◽

Castration Resistant ◽

Use of New Therapies and Hospital Admission Near the End of Life in Castration Resistant Prostate Cancer (CRPC) in the Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

Value in Health ◽

10.1016/j.jval.2017.08.009 ◽

2017 ◽

Vol 20 (9) ◽

pp. A400

Author(s):

M Kuppen ◽

H Westgeest ◽

A Van den Eertwegh ◽

W Gerritsen ◽

C Uyl - de Groot

Keyword(s):

Prostate Cancer ◽

The Netherlands ◽

Hospital Admission ◽

End Of Life ◽

Cancer Registry ◽

New Therapies ◽

Castration Resistant

PD16-08 EFFECT OF CABAZITAXEL VS ABIRATERONE OR ENZALUTAMIDE ON PATIENT-REPORTED OUTCOMES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

The Journal of Urology ◽

10.1097/ju.0000000000000859.08 ◽

2020 ◽

Vol 203 ◽

pp. e366

Author(s):

Gero Kramer* ◽

Cora N. Sternberg ◽

Karim Fizazi ◽

Bertrand Tombal ◽

Jean-Christophe Eymard ◽

...

Keyword(s):

Prostate Cancer ◽

Castration Resistant ◽

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health ◽

10.1016/j.jval.2013.08.561 ◽

2013 ◽

Vol 16 (7) ◽

pp. A421

Author(s):

S. Aggarwal ◽

J. Segal ◽

S. Kumar

Keyword(s):

Prostate Cancer ◽

Castration Resistant ◽

MP52-20 PATIENT REPORTED OUTCOMES (PROS) IN SPARTAN, A PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY OF APALUTAMIDE (APA) PLUS ANDROGEN DEPRIVATION THERAPY (ADT) VS PLACEBO PLUS ADT IN MEN WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)

The Journal of Urology ◽

10.1016/j.juro.2018.02.1671 ◽

2018 ◽

Vol 199 (4S) ◽

Cited By ~ 1

Author(s):

Eric J. Small ◽

Fred Saad ◽

Boris A. Hadaschik ◽

Julie N. Graff ◽

Paul N. Mainwaring ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Randomized Study ◽

Androgen Deprivation ◽

Phase 3 ◽

Double Blind ◽

Castration Resistant ◽

Patient Reported Outcomes in Castration-Resistant Prostate Cancer

Value in Health ◽

10.1016/j.jval.2014.03.547 ◽

2014 ◽

Vol 17 (3) ◽

pp. A94

Author(s):

S. Aggarwal ◽

J. Segal

Keyword(s):

Prostate Cancer ◽

Castration Resistant ◽

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

Journal of Patient-Reported Outcomes ◽

10.1186/s41687-018-0054-5 ◽

2018 ◽

Vol 2 (1) ◽

Cited By ~ 6

Author(s):

Joseph M. Unger ◽

Katherine Griffin ◽

Gary W. Donaldson ◽

Karen M. Baranowski ◽

Margorie J. Good ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Castration Resistant ◽

Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study

European Urology ◽

10.1016/j.eururo.2019.09.019 ◽

2020 ◽

Vol 77 (3) ◽

pp. 380-387 ◽

Cited By ~ 5

Author(s):

Antoine Thiery-Vuillemin ◽

Mads Hvid Poulsen ◽

Edouard Lagneau ◽

Guillaume Ploussard ◽

Alison Birtle ◽

...

Keyword(s):

Prostate Cancer ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Relationship between patient-reported outcomes and clinical outcomes in metastatic castration-resistant prostate cancer: post hoc analysis of COU-AA-301 and COU-AA-302

Annals of Oncology ◽

10.1093/annonc/mdx759 ◽

2018 ◽

Vol 29 (2) ◽

pp. 392-397 ◽

Cited By ~ 14

Author(s):

D. Cella ◽

S. Traina ◽

T. Li ◽

K. Johnson ◽

K.F. Ho ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcomes ◽

Post Hoc Analysis ◽

Castration Resistant ◽

Patient Reported ◽

Post Hoc